Cholecystokinin (CCK) is produced by discrete enteric endocrine cells (I cells) of the proximal small intestine and secreted into the blood upon ingestion of food. However, the exact nature by which the CCK cell is regulated is unknown. Recently, the PI has developed a method for studying CCK cells in vitro. These cells respond to a variety of physiological stimuli including the novel CCK releasing factors, monitor peptide and luminal CCK releasing factor (LCRF). Although these cells can be enriched they are not a pure population of enteric endocrine cells. Therefore, the PI has recently characterized an intestinal cell line (STC -1) that produces high amounts of CCK and exhibits properties characteristic of native enteric CCK cells. This established cell line secretes CCK in a regulated manner that is indistinguishable from native CCK cells and has been used as a model for studying electrophysiological properties of intestinal hormone secretion. In other endocrine systems hormone secretion is intimately coupled to plasma membrane ion channel activity. The PI has previously demonstrated that maneuvers that cause membrane depolarization in STC-1 cells induce CCK secretion. Using patch clamp recording techniques it has been shown that CCK-secreting cells have a prominent basal potassium current. Moreover, calcium channel activity appears to be critical for CCK release. These findings suggest that regulation of ion channel activity in CCK cells may be important for regulated CCK secretion. The hypothesis to be tested in the current proposal is that CCK releasing factors regulate plasma membrane ion channel activity in intestinal endocrine cells to stimulate hormone secretion. For these studies, ion channel activity will be measured using patch clamp recording techniques and membrane potential will be measured with conventional microelectrodes. The following specific aims will be addressed: 1. To determine whether CCK secretion induced by monitor peptide and LCRF occurs through changes in membrane depolarization or by direct effects on ion channels. 2. To characterize the specific potassium channels which are regulated hi CCK cells by releasing factors. 3. To identify the calcium channels that are regulated by monitor peptide and LCRF. Together these studies will determine how intestinal releasing factors regulate CCK secretion. state)

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37DK038626-21
Application #
7250104
Study Section
Special Emphasis Panel (NSS)
Program Officer
May, Michael K
Project Start
1988-07-14
Project End
2009-06-30
Budget Start
2007-07-01
Budget End
2008-06-30
Support Year
21
Fiscal Year
2007
Total Cost
$432,321
Indirect Cost
Name
Duke University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Shah, Tilak Upendra; Liddle, Rodger; Branch, M Stanley et al. (2012) Pilot study of aprepitant for prevention of post-ERCP pancreatitis in high risk patients: a phase II randomized, double-blind placebo controlled trial. JOP 13:514-8
Bohórquez, Diego V; Liddle, Rodger A (2011) Axon-like basal processes in enteroendocrine cells: characteristics and potential targets. Clin Transl Sci 4:387-91
Chandra, Rashmi; Liddle, Rodger A (2011) Recent advances in pancreatic endocrine and exocrine secretion. Curr Opin Gastroenterol 27:439-43
Bohórquez, Diego V; Chandra, Rashmi; Samsa, Leigh Ann et al. (2011) Characterization of basal pseudopod-like processes in ileal and colonic PYY cells. J Mol Histol 42:3-13
Wang, Yu; Chandra, Rashmi; Samsa, Leigh Ann et al. (2011) Amino acids stimulate cholecystokinin release through the Ca2+-sensing receptor. Am J Physiol Gastrointest Liver Physiol 300:G528-37
Chandra, Rashmi; Samsa, Leigh Ann; Vigna, Steven R et al. (2010) Pseudopod-like basal cell processes in intestinal cholecystokinin cells. Cell Tissue Res 341:289-97
Romac, Joelle M-J; Ohmuraya, Masaki; Bittner, Cathy et al. (2010) Transgenic expression of pancreatic secretory trypsin inhibitor-1 rescues SPINK3-deficient mice and restores a normal pancreatic phenotype. Am J Physiol Gastrointest Liver Physiol 298:G518-24
Nathan, Jaimie D; Romac, Joelle; Peng, Ruth Y et al. (2010) Protection against chronic pancreatitis and pancreatic fibrosis in mice overexpressing pancreatic secretory trypsin inhibitor. Pancreas 39:e24-30
Chandra, Rashmi; Liddle, Rodger A (2009) Neural and hormonal regulation of pancreatic secretion. Curr Opin Gastroenterol 25:441-6
Liddle, Rodger A (2006) Pathophysiology of SPINK mutations in pancreatic development and disease. Endocrinol Metab Clin North Am 35:345-56, x

Showing the most recent 10 out of 68 publications